CFO departure
Seres Therapeutics, Inc. discloses CFO departure: Marella Thorell
Seres Therapeutics, Inc. reported in a Form 8-K filed October 26, 2026 a change involving its Chief Financial Officer, Marella Thorell, effective November 15, 2026. The filing's own words are quoted below.
In the filing's words
On October 22, 2026, Marella Thorell, Executive Vice President and Chief Financial Officer of Seres Therapeutics, Inc. (the “Company”), resigned from her positions as Executive Vice President and Chief Financial Officer of the Company, effective November 15, 2026 (the “Effective Date”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Seres Therapeutics, Inc. (MCRB) |
|---|---|
| Event | Departure |
| Outgoing | Marella Thorell |
| Effective | November 15, 2026 |
| 8-K filed | October 26, 2026 |
| SEC CIK | 0001609809 |
Seres Therapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed October 26, 2026. The filing's own words are quoted above.
Also filed in October 2026
Other CFO moves on the record that month. All moves.
yesterday· 2026-10-26TransitionAZO
AutoZone, Inc CFO transition: J. Scott Murphy to succeed Jamere Jackson
yesterday· 2026-10-26DepartureCLW
Clearwater Paper Corp discloses CFO departure: Sherri Baker
yesterday· 2026-10-26TransitionFDX
FedEx Corporation CFO transition: Jamere Jackson to succeed Claude F. Russ
yesterday· 2026-10-26TransitionGYGY
Game Your Game Inc. CFO transition: Wendy Loundermon to succeed Dominic Poole
4 days ago· 2026-10-23Transition
AB Commercial Real Estate Private Debt Fund, LLC CFO transition: Shane McGrogan to succeed Marguerite Brogan
4 days ago· 2026-10-23DepartureAMSS
AMASS Brands Inc. discloses CFO departure: Zachary Ament
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-10-26
Something wrong about Marella Thorell? Send a correction with the primary source.